YU57999A - N-triazolil-2-indolkarboksamidi i njihova primena kao agonista za cck-a - Google Patents

N-triazolil-2-indolkarboksamidi i njihova primena kao agonista za cck-a

Info

Publication number
YU57999A
YU57999A YU57999A YU57999A YU57999A YU 57999 A YU57999 A YU 57999A YU 57999 A YU57999 A YU 57999A YU 57999 A YU57999 A YU 57999A YU 57999 A YU57999 A YU 57999A
Authority
YU
Yugoslavia
Prior art keywords
indolecarboxamides
ccka
triazolyl
agonists
compounds
Prior art date
Application number
YU57999A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Eric Bignon
Jean Pierre Brass
Paul De Cointet
Pierre Despeyroux
Daniel Frehel
Danielle Gully
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of YU57999A publication Critical patent/YU57999A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
YU57999A 1997-05-13 1998-05-06 N-triazolil-2-indolkarboksamidi i njihova primena kao agonista za cck-a YU57999A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
YU57999A true YU57999A (sh) 2002-06-19

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
YU57999A YU57999A (sh) 1997-05-13 1998-05-06 N-triazolil-2-indolkarboksamidi i njihova primena kao agonista za cck-a

Country Status (35)

Country Link
EP (1) EP0984960B1 (fr)
JP (1) JP2001524980A (fr)
KR (1) KR20010012541A (fr)
CN (1) CN1263528A (fr)
AR (1) AR011729A1 (fr)
AT (1) ATE232207T1 (fr)
AU (1) AU725530B2 (fr)
BR (1) BR9811465A (fr)
CA (1) CA2289573A1 (fr)
CO (1) CO4940485A1 (fr)
CZ (1) CZ289484B6 (fr)
DE (1) DE69811223T2 (fr)
DK (1) DK0984960T3 (fr)
DZ (1) DZ2486A1 (fr)
EE (1) EE9900524A (fr)
ES (1) ES2190081T3 (fr)
FR (1) FR2763337B1 (fr)
GT (1) GT199800068A (fr)
HR (1) HRP980258B1 (fr)
HU (1) HUP0002763A3 (fr)
ID (1) ID22911A (fr)
IL (1) IL132903A0 (fr)
IS (1) IS5235A (fr)
NO (1) NO995513L (fr)
NZ (1) NZ500637A (fr)
PL (1) PL336772A1 (fr)
RU (1) RU2175323C2 (fr)
SI (1) SI0984960T1 (fr)
SK (1) SK154299A3 (fr)
TR (1) TR199902795T2 (fr)
TW (1) TW396155B (fr)
UY (1) UY24997A1 (fr)
WO (1) WO1998051686A1 (fr)
YU (1) YU57999A (fr)
ZA (1) ZA983997B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
AU2002226330A1 (en) * 2000-10-26 2002-05-06 Sanofi-Synthelabo Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
US20050014805A1 (en) * 2001-10-12 2005-01-20 Chenzhi Zhang Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (fr) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides comme inhibiteurs du facteur Xa
EP1479677A1 (fr) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Nouveaux derivés d'indole en tant qu'inhibiteurs du facteur xa
EP1532980A1 (fr) * 2003-11-24 2005-05-25 Novo Nordisk A/S Carboxamides d'indole n-heteroarylé et leurs analogues, utiles comme des activateurs de glucokinase pour le traitement de diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
ATE528006T1 (de) * 2007-01-26 2011-10-15 Merck Sharp & Dohme Substituierte aminopyrimidine als cholecystokinin-1-rezeptormodulatoren
WO2010007046A2 (fr) * 2008-07-15 2010-01-21 Novartis Ag Composés organiques
US8580831B2 (en) * 2009-06-09 2013-11-12 Actelion Pharmaceuticals Ltd. Fluorinated aminotriazole derivatives
EP2490659B1 (fr) * 2009-10-22 2017-03-01 Henkel AG & Co. KGaA Produit pour le maintien de la chevelure comprenant un amidon non ionique modifié par de l'oxyde de proprylène et un chitosan
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
MX2022004142A (es) 2019-10-07 2022-09-21 Kallyope Inc Agonistas de gpr119.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
IL132903A0 (en) 2001-03-19
AR011729A1 (es) 2000-08-30
TW396155B (en) 2000-07-01
ID22911A (id) 1999-12-16
FR2763337A1 (fr) 1998-11-20
CN1263528A (zh) 2000-08-16
NO995513D0 (no) 1999-11-11
SI0984960T1 (en) 2003-06-30
FR2763337B1 (fr) 1999-08-20
UY24997A1 (es) 2000-10-31
EP0984960B1 (fr) 2003-02-05
DZ2486A1 (fr) 2003-02-01
IS5235A (is) 1999-10-29
DK0984960T3 (da) 2003-05-26
EP0984960A1 (fr) 2000-03-15
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
NO995513L (no) 2000-01-12
NZ500637A (en) 2000-11-24
DE69811223T2 (de) 2003-11-27
BR9811465A (pt) 2000-09-12
HUP0002763A3 (en) 2002-05-28
HRP980258B1 (en) 2002-08-31
RU2175323C2 (ru) 2001-10-27
PL336772A1 (en) 2000-07-17
KR20010012541A (ko) 2001-02-15
AU725530B2 (en) 2000-10-12
GT199800068A (es) 1999-11-11
EE9900524A (et) 2000-06-15
ZA983997B (en) 1999-11-12
HRP980258A2 (en) 1999-02-28
CO4940485A1 (es) 2000-07-24
JP2001524980A (ja) 2001-12-04
ATE232207T1 (de) 2003-02-15
WO1998051686A1 (fr) 1998-11-19
SK154299A3 (en) 2000-05-16
CZ289484B6 (cs) 2002-01-16
CZ400699A3 (cs) 2000-02-16
DE69811223D1 (de) 2003-03-13
ES2190081T3 (es) 2003-07-16
TR199902795T2 (xx) 2000-02-21
HUP0002763A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
YU57999A (sh) N-triazolil-2-indolkarboksamidi i njihova primena kao agonista za cck-a
MXPA02006086A (es) Inhibidores triciclicos de proteina-cinasas.
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
IL154981A0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
AP1718A (en) 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
IL144147A0 (en) Regulators of the pct or smoothened pathway, compositions and uses related thereto
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
MXPA02005792A (es) 1-(aminofenil)-2-pirrolidonas como inhibidores de la integrina.
BG103548A (en) Vitronectine receptor antagonists
DE69905170D1 (en) Thiazolopyrimidinderivate
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
AU2002360733A8 (en) Substituted 4,9-dihydrocyclopenta(imn)phenanthridine-5-ones derivatives thereof and their uses
BG104916A (en) Calcilytic compounds
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
HK1032785A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
MY126868A (en) Suspension comprising oxcarbazepine
MXPA03001783A (es) N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.